Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

4 Stocks Running Up: BBEP, LGND, OREX, SRNE

Published 03/04/2015, 12:22 AM
Updated 07/09/2023, 06:31 AM

It was a sloppy day on Wall Street yesterday. The markets were looking toppy, but many of the stocks we trade really did well, in the right sector at the right time, of course.

Breitburn Energy Partners L.P (NASDAQ:BBEP) is one of the better looking junior oils. After coming down and forming a left shoulder-head-right shoulder, with the right shoulder being more of a falling wedge, it popped on Tuesday, up 67 cents to 7.88, or 7.8%, on 8 million shares. It’s going to have a little bit of resistance at about the 8.15 level on Wednesday, but it may very well test higher levels at 8.99, which would be the resistance zone. If it gets through that, the targets are 10 1/4, and then 12 1/4.

Ligand Pharmaceuticals (NASDAQ:LGND), after the big run-up, had a sharp pullback at 80 down to the low 40’s in a 5-wave decline, taking about nine months or so, and then it ran up to resistance, pulled back, formed a kind of right shoulder, then a left-shoulder, then a right shoulder, inverse-type shoulder. It had a fantastic breakout on Monday, and then again on Tuesday, up 2.87 to 66.45, or 4.5%, on a million shares. Look for a run to test the 70-71 zone short-term. Secondary target is near the 79-80 zone.

Orexigen Therapeutics, (NASDAQ:OREX) had a monster day on Tuesday, up 1.85 to 7.64, or 32%, on 95 million shares. That number of shares is unheard of for this stock. It has a massive double left shoulder-head-right shoulder, the neckline was broken, so was secondary resistance, and then it popped all the way up to the upper channel before backing off. It did give back about 1.70, but still closed up 1.85, so it closed just above midrange. Let’s see what kind of follow-through it gets. The targets going forward are 9:00 and 11.00.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Sorrento Therapeutics, (NASDAQ:SRNE) has been acting well. In good or bad markets its been holding steady. It did have a little bit of a 4-day pullback. On Tuesday it reversed from 12.60 to 13.26, and closed 6 cents off the high at 13.20, or 2.6%, on 123,600 shares. A nice reversal, not a lot of volume. See if it can get through the 13.26 area, and then move into the 15-dollar area.

Other stocks on Harry’s Charts of the Day included Advaxis, (NASDAQ:ADXS), Ambarella, (NASDAQ:AMBA), Capnia, (NASDAQ:CAPN), Gogo (NASDAQ:GOGO), Merrimack Pharmaceuticals, (NASDAQ:MACK), McDermott International (NYSE:MDR), NewLink Genetics (NASDAQ:NLNK), Ohr Pharmaceutical, (NASDAQ:OHRP), Sanchez Energy (NYSE:SN), Tower Semiconductor TSEM)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.